| Members |
targetComponentId |
| Decubitus mamma |
Pressure injury of breast (disorder) |
| Decubitussår på fodryg |
Pressure injury of dorsum of foot |
| Decubitus på hofte |
Pressure injury of hip |
| decubitussår på nederste del af ryggen |
Pressure injury of lumbar region of back |
| Liggesår (Decubitus) i natal revne |
Pressure injury of natal cleft (disorder) |
| Deep circumflex iliac artery flap |
Deep circumflex iliac artery bone flap (substance) |
| struktur af dyb pektoralmuskel |
Pectoral muscle structure |
| Deep pressure sore |
Pressure injury of deep tissue (disorder) |
| Dybt tryksår |
Pressure injury of deep tissue (disorder) |
| dyb tværstand med antenatalt problem |
Deep transverse arrest |
| Deficiency of N-acetylgalactosamine-6-sulfatase |
Deficiency of N-acetylgalactosamine-6-sulfatase |
| Deficiency of N-acetylglucosamine-6-sulfatase |
Mucopolysaccharidosis, MPS-III-D |
| O-Acetylserin(thiol)-lyasemangel |
Specific enzyme deficiency (disorder) |
| Deficiency of amniotic fluid production (disorder) |
Disorder of amniotic fluid production |
| Deficiency of amniotic fluid turnover (disorder) |
Disorder of amniotic fluid turnover |
| Deficiency of dihydrolipoamide dehydrogenase |
Dihydrolipoamide dehydrogenase deficiency |
| Deficiency of glutamate formyltransferase |
Glutamate formiminotransferase deficiency |
| Deficiency of glycerate dehydrogenase |
Primary hyperoxaluria, type II |
| Deficiency of glyoxylate reductase |
Primary hyperoxaluria, type II |
| Deficiency of iduronate-2-sulfatase |
Mucopolysaccharidosis, MPS-II |
| Deficiency of ornithine carbamoyltransferase |
Ornithine carbamoyltransferase deficiency |
| Deficiency of placental circulatory function |
Disorder of placental circulatory function |
| Deficiency of purine-nucleoside phosphorylase |
Purine-nucleoside phosphorylase deficiency |
| Deficiency of pyruvic dehydrogenase |
Pyruvate dehydrogenase complex deficiency |
| Deficient knowledge of traditional therapy |
Deficient knowledge of complementary therapy |
| Defluvibacter lusatiensis |
Aquamicrobium lusatiense (organism) |
| Deformity due to adhesions |
Deformity (morphologic abnormality) |
| Degeneration of iris AND/OR ciliary body |
Disorder of uveal tract |
| Degenerativ kolloid atrofi |
Colloid milium (disorder) |
| Degenerative joint disease of thigh |
Disorder of lower limb |
| Degenerative lesion of articular cartilage of knee |
Degenerative disorder of articular cartilage of knee (disorder) |
| Degenerativ ledbrusklæsion i knæet |
Degenerative disorder of articular cartilage of knee (disorder) |
| Degree elevation of head of bed for tube feeding of patient |
The angle, expressed in degrees, that the head of the bed is raised during delivery of enteral nutrition feeding. |
| Dehydrogenase |
Substance with dehydrogenase mechanism of action (substance) |
| Delay in sexual development and puberty, NEC |
Delay in sexual development AND/OR puberty |
| Delayed |
Delayed priority |
| Delayed allergy to red meat |
An allergic condition in which people are allergic to alpha-gal, a sugar found in the tissues of all mammals except humans and other primates. When people who are allergic to alpha-gal eat beef, pork, lamb, or meat from other mammals, they have an allergic reaction that causes a range of symptoms, including a rash, nausea, vomiting, and diarrhoea. In some cases, there may be an immediate life-threatening anaphylactic reaction. Many report that allergic symptoms to meat began after a series of tick bites. The tick species most often implicated in meat allergy have been Amblyomma americanum (the lone star tick) in the eastern, southeastern, and south-central parts of the United States and other species (Ixodes ricinus, Ixodes holocyclus, Amblyomma cajennense, Amblyomma sculptum, and Haemaphysalis longicornis) in other parts of the world. |
| forsinket konjugering medførende neonatal icterus, ikke nærmere specificeret |
Neonatal jaundice due to delayed conjugation |
| forsinket forløsning af 2. tvilling med prænatalt problem |
Delayed delivery of second twin |
| Delayed exfoliation of primary teeth |
Persistent primary tooth (disorder) |
| forsinket heling af operationssår |
Delayed healing of surgical wound (finding) |
| Delayed healing surgical wound |
Delayed healing of surgical wound (finding) |
| Delayed healing surgical wound |
Delayed healing of surgical wound (finding) |
| forsinket eller kraftig blødning, ikke nærmere specificeret, efter graviditet med abort som udfald |
Disorder following induced termination of pregnancy (disorder) |
| Delayed or excessive hemorrhage NOS following abortive pregnancy |
Disorder following induced termination of pregnancy (disorder) |
| Delayed primary suture of skin NEC |
Delayed primary suture of skin |
| Deletion of long arm of chromosome 17 |
A partial deletion of the long arm of chromosome 17 characterized by hypotonia, growth delay, severe global developmental delay, microcephaly, seizures, congenital heart anomalies, hand and foot anomalies (syndactyly, symphalangism) and dysmorphic facial features, including round face, hypertelorism, upslanting palpebral fissures, and micrognathia. Reported deletions involve regions 17q21-q24. |
| Delirium caused by substance or medication |
Delirium |
| Delivery booking - place NOS |
Delivery place booking (procedure) |
| Delivery booking - place NOS |
Delivery place booked |
| Delivery booking - stay NOS |
Delivery booking - length of stay (finding) |
| Delivery booking - stay NOS |
Delivery length of stay booking (procedure) |
| forløsningsrisiko |
At increased risk for complication during labour and delivery |
| Delta hepatitis viral agent |
Hepatitis D virus (organism) |
| (s) delta-9-tetrahydrocannabinol 27 mg/ml og cannabinol 25 mg/ml, spray til bukkal anvendelse |
Product containing precisely cannabidiol 25 milligram/1 milliliter and delta-9-tetrahydrocannabinol 27 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
| dement slægtning |
Family history of dementia (situation) |
| Dementia following injury caused by exposure to ionizing radiation |
Dementia caused by ionizing radiation |
| Demineralization of enamel of teeth |
Incipient enamel caries |
| Demonstrates knowledge of traditional therapy |
Demonstrates knowledge of complementary therapy (finding) |
| dendritisk cellesarkom, ikke nærmere specificeret |
Dendritic cell sarcoma |
| Dendroaspis viridis |
Dendroaspis angusticeps |
| Dendrocygnini |
Subfamily Dendrocygninae (organism) |
| Dental diseases and conditions NOS |
Disorder of teeth AND/OR supporting structures (disorder) |
| Dental diseases and conditions NOS |
Disorder of teeth AND/OR supporting structures (disorder) |
| Dental practitioner NOS |
Dentist |
| Dental practitioner NOS |
Dentist |
| Denver-shunt |
Peritoneovenous shunt |
| test for Denver shunt-patency |
Peritoneovenous shunt patency test |
| Deoxycortisol |
Cortodoxone (substance) |
| Deoxycortisone |
Cortodoxone (substance) |
| Deoxyribonucleic acid of Aeromonas salmonicida |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of African swine fever virus |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Alcelaphine herpesvirus 1 |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Avipoxvirus |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Caprine arthritis encephalitis virus |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Capripoxvirus |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Cowdria ruminantium |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Equine herpesvirus 1 |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Equine herpesvirus 4 |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Feline herpesvirus 1 |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Lumpy skin disease virus |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Marek's disease virus |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Mycoplasma agalactiae |
Mycoplasma DNA |
| Deoxyribonucleic acid of Mycoplasma gallisepticum |
Mycoplasma DNA |
| Deoxyribonucleic acid of Ovine herpesvirus 2 |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Ovine progressive pneumonia virus |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Pseudorabies virus |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Taylorella equigenitalis |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Theileria mutans |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Theileria parva |
Deoxyribonucleic acid of microorganism (substance) |
| Deoxyribonucleic acid of Trypanosoma evansi |
Deoxyribonucleic acid of microorganism (substance) |
| Department of Health and Social Security (DHSS) medical examination NOS |
Specialized medical examination |
| Dependence caused by dissociative substance |
Hallucinogen dependence |
| afhængighed af ukendt stof |
The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months. |
| Dependent territories of United Kingdom of Great Britain and Northern Ireland |
British Overseas Territories (geographic location) |
| Depo-provera-injektion |
Injection of medroxyprogesterone acetate (procedure) |
| Deposition of sodium urate crystals with inflammatory morphology |
Deposition of monosodium urate crystals with inflammatory morphology |
| Depot contraceptive NOS |
Depot contraceptive status |
| Depot contraceptive NOS |
Depot contraceptive status |
| administration af kontraceptivum i depotform |
Administration of depot contraceptive (procedure) |
| Depression NOS |
Depressive disorder |
FHIR